| Funding Opportunity |
Limited Competition: The Chernobyl Tissue Bank - Coordinating Center (U24)
Funding Number: RFA CA 16 502
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $300,000 |
U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer (R21)
Funding Number: RFA CA 16 015
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $100,000 |
Cancer Target Discovery and Development Network (U01)
Funding Number: RFA CA 16 014
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $750,000 |
U.S.-Russia Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and HIV-Associated Comorbidities (R01)
Funding Number: RFA AA 17 006
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $200,000 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01)
Funding Number: PAR 16 338
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21)
Funding Number: PAR 16 336
Agency: HHS-NIH11
Funding Amount: $200,000 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03)
Funding Number: PAR 16 337
Agency: HHS-NIH11
Funding Amount: $50,000 |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21)
Funding Number: PAR 16 318
Agency: HHS-NIH11
Funding Amount: $200,000 |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01)
Funding Number: PAR 16 317
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24)
Funding Number: RFA AA 17 004
Agency: HHS-NIH11
Funding Amount: $350,000 |
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24)
Funding Number: RFA AA 17 005
Agency: HHS-NIH11
Funding Amount: $600,000 |
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01)
Funding Number: RFA AA 17 003
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Integrative Research on Polysubstance Abuse and Addiction (R21/R33)
Funding Number: PAR 16 291
Agency: HHS-NIH11
Funding Amount: $200,000 |
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21)
Funding Number: PAR 16 292
Agency: HHS-NIH11
Funding Amount: $125,000 |
The NCI Transition Career Development Award (K22)
Funding Number: PAR 16 293
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Silencing of HIV-1 Proviruses (R61/R33)
Funding Number: RFA AI 16 038
Agency: HHS-NIH11
Funding Amount: $500,000 |
Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07)
Funding Number: PAR 16 284
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21)
Funding Number: PAR 16 277
Agency: HHS-NIH11
Funding Amount: $200,000 |
Planning Grant for Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D71)
Funding Number: PAR 16 281
Agency: HHS-NIH11
Funding Amount: $28,000 |
Prescription Drug Abuse (R21)
Funding Number: PA 16 232
Agency: HHS-NIH11
Funding Amount: $200,000 |
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21)
Funding Number: PAR 16 278
Agency: HHS-NIH11
Funding Amount: $200,000 |
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11)
Funding Number: PAR 16 280
Agency: HHS-NIH11
Funding Amount: $92,000 |
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43)
Funding Number: PAR 16 279
Agency: HHS-NIH11
Funding Amount: $280,000 |
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01)
Funding Number: PAR 16 276
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Serious Adverse Drug Reaction Research (R01)
Funding Number: PAR 16 275
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Serious Adverse Drug Reaction Research (R21)
Funding Number: PAR 16 274
Agency: HHS-NIH11
Funding Amount: $200,000 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01)
Funding Number: PAR 16 266
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Methodology and Measurement in the Behavioral and Social Sciences (R21)
Funding Number: PAR 16 261
Agency: HHS-NIH11
Funding Amount: $200,000 |
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21)
Funding Number: PA 16 258
Agency: HHS-NIH11
Funding Amount: $200,000 |
Methodology and Measurement in the Behavioral and Social Sciences (R01)
Funding Number: PAR 16 260
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Cancer-related Behavioral Research through Integrating Existing Data (R01)
Funding Number: PAR 16 256
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Cancer-related Behavioral Research through Integrating Existing Data (R21)
Funding Number: PAR 16 255
Agency: HHS-NIH11
Funding Amount: $200,000 |
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21)
Funding Number: PAR 16 257
Agency: HHS-NIH11
Funding Amount: $200,000 |
Building Evidence: Effective Palliative/End of Life Care Interventions (R01)
Funding Number: PAR 16 250
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)
Funding Number: PAR 16 234
Agency: HHS-NIH11
Funding Amount: $500,000 |
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21)
Funding Number: PAR 16 248
Agency: HHS-NIH11
Funding Amount: $200,000 |
Gene Fusions in Pediatric Sarcomas (R21)
Funding Number: PA 16 252
Agency: HHS-NIH11
Funding Amount: $200,000 |
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01)
Funding Number: PAR 16 249
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Gene Fusions in Pediatric Sarcomas (R01)
Funding Number: PA 16 251
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Prescription Drug Abuse (R01)
Funding Number: PA 16 233
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Neural Regulation of Cancer (R21)
Funding Number: PAR 16 246
Agency: HHS-NIH11
Funding Amount: $200,000 |
Neural Regulation of Cancer (R01)
Funding Number: PAR 16 245
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites (U01)
Funding Number: RFA HG 16 010
Agency: HHS-NIH11
Funding Amount: $2,000,000 |
Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites with Enhanced Diversity (U01)
Funding Number: RFA HG 16 011
Agency: HHS-NIH11
Funding Amount: $2,500,000 |
Metabolic Reprogramming to Improve Immunotherapy (R01)
Funding Number: PAR 16 228
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Non-healing Ulcerative Wounds in Aging (R01)
Funding Number: PA 16 230
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Metabolic Reprogramming to Improve Immunotherapy (R21)
Funding Number: PAR 16 229
Agency: HHS-NIH11
Funding Amount: $200,000 |
The Role of Mobile Genetic Elements in Cancer (R01)
Funding Number: PAR 16 227
Agency: HHS-NIH11
Funding Amount: Case Dependent |
NIDA Research Education Program for Clinical Researchers and Clinicians (R25)
Funding Number: PAR 16 224
Agency: HHS-NIH11
Funding Amount: $350,000 |
The Role of Mobile Genetic Elements in Cancer (R21)
Funding Number: PAR 16 226
Agency: HHS-NIH11
Funding Amount: $200,000 |
